The dual burden of diabetes and myocardial infarction in low- and middle-income countries requires targeted investments in healthcare infrastructure, patient education, and scalable interventions.
Improving outcomes for patients with diabetes and myocardial infarction in LMICs requires targeted investment in healthcare infrastructure, patient education, and scalable interventions like community-based care and digital tools.
ABSTRACT Background and Aim The dual burden of diabetes and myocardial infarction (MI) significantly increases morbidity and mortality, especially in low‐ and middle‐income countries (LMICs). This study evaluates current treatment strategies, emphasizing the impact of limited access to medications, diagnostics, and specialized care. It proposes adaptable solutions tailored to resource‐constrained settings. Method For this review study, we investigated many databases—including PubMed, Scopus, Embase, Web of Science, Google Scholar, and the Cochrane Library—using different relevant terms. Discussion Low public awareness and healthcare limitations often delay diagnosis and treatment, leading to poor outcomes. While comprehensive care, including medication, lifestyle modification, and education, is ideal, it remains out of reach for many LMICs due to systemic barriers. Conclusion Improving chronic disease outcomes in LMICs requires targeted investment in healthcare infrastructure, patient education, and scalable interventions. Community‐based care, digital tools, and task‐shifting models show strong potential for enhancing disease management.
Rafi et al. (Wed,) conducted a review in Diabetes and myocardial infarction. The dual burden of diabetes and myocardial infarction in low- and middle-income countries requires targeted investments in healthcare infrastructure, patient education, and scalable interventions.